These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33664733)

  • 41. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
    Anderson-Smits C; Baker ER; Hirji I
    Transpl Infect Dis; 2020 Dec; 22(6):e13396. PubMed ID: 32603496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
    Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
    Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
    Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kheav VD; Busson M; Scieux C; Peffault de Latour R; Maki G; Haas P; Mazeron MC; Carmagnat M; Masson E; Xhaard A; Robin M; Ribaud P; Dulphy N; Loiseau P; Charron D; Socié G; Toubert A; Moins-Teisserenc H
    Haematologica; 2014 Dec; 99(12):1860-7. PubMed ID: 25085354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34
    Huang YT; Kim SJ; Lee YJ; Burack D; Nichols P; Maloy M; Perales MA; Giralt SA; Jakubowski AA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1759-1766. PubMed ID: 28668490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children.
    Jeljeli M; Guérin-El Khourouj V; Porcher R; Fahd M; Leveillé S; Yakouben K; Ouachée-Chardin M; LeGoff J; Cordeiro DJ; Pédron B; Baruchel A; Dalle JH; Sterkers G
    Br J Haematol; 2014 Jul; 166(2):229-39. PubMed ID: 24702221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted dosing of anti-thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single-arm, phase 2 trial.
    Wang H; Wang N; Wang L; Du J; Li F; Shao Y; Peng B; Luan S; Wang L; Jin X; Gao C; Dou L; Liu D
    Am J Hematol; 2023 Nov; 98(11):1732-1741. PubMed ID: 37706580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.
    Yoon JH; Lee S; Kim HJ; Jeon YW; Lee SE; Cho BS; Lee DG; Eom KS; Kim YJ; Min CK; Cho SG; Min WS; Lee JW
    Oncotarget; 2016 Mar; 7(13):17230-41. PubMed ID: 26883100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.
    Tey SK; Kennedy GA; Cromer D; Davenport MP; Walker S; Jones LI; Crough T; Durrant ST; Morton JA; Butler JP; Misra AK; Hill GR; Khanna R
    PLoS One; 2013; 8(10):e74744. PubMed ID: 24146744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group.
    Kimura SI; Tamaki M; Okinaka K; Seo S; Uchida N; Igarashi A; Ozawa Y; Ikegame K; Eto T; Tanaka M; Shiratori S; Nakamae H; Sawa M; Kawakita T; Onizuka M; Fukuda T; Atsuta Y; Kanda Y; Nakasone H
    Ann Hematol; 2021 Dec; 100(12):3029-3038. PubMed ID: 34490500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation.
    Tsushima T; Masuda SI; Yoda N; Kainuma S; Kimeda C; Konno S; Tanaka K; Matsuo K; Shimoji S; Kimura K; Arai H; Utsu Y; Imadome KI; Aotsuka N
    Ann Hematol; 2024 Mar; 103(3):935-946. PubMed ID: 38157001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delay expression of NKp30 on NK cells correlates with long-term mycophenolate mofetil treatment and higher EBV viremia post allogenic hematological stem cells transplantation.
    Yu XX; Cao XH; Yan H; Luo XY; Zhao XS; Sun YQ; Wang Y; Xu LP; Zhang XH; Chang YJ; Huang XJ; Zhao XY
    Clin Immunol; 2019 Aug; 205():49-56. PubMed ID: 31112757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.
    Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E
    J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expansion of effector memory Vδ2
    Huang Y; Jiang C; Zhu J; Lin L; Mao M; Yin T; Cai G
    Front Immunol; 2024; 15():1397483. PubMed ID: 38915409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
    Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
    Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EBV-PTLD, Adenovirus, and CMV in Pediatric Allogeneic Transplants With Alemtuzumab as Part of Pretransplant Conditioning: A Retrospective Single Center Study.
    Cupit-Link MC; Nageswara Rao A; Warad DM; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):e473-e478. PubMed ID: 29620685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
    Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
    J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.